These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24771634)

  • 21. Characterization of the relationship between serum and milk residue disposition of ceftriaxone in lactating ewes.
    Goudah A; Shin HC; Shim JH; Abd El-Aty AM
    J Vet Pharmacol Ther; 2006 Aug; 29(4):307-12. PubMed ID: 16846468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and safety of ceftriaxone in the neonate.
    Mulhall A; de Louvois J; James J
    Eur J Pediatr; 1985 Nov; 144(4):379-82. PubMed ID: 4076254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery.
    Martin C; Ragni J; Lokiec F; Guillen JC; Auge A; Pecking M; Gouin F
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2804-7. PubMed ID: 1482149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of ceftriaxione, a third-generation cephalosporin, in pediatric patients.
    Fukumoto K; Aida S; Oishi T; Ueno K
    Biol Pharm Bull; 2009 Jul; 32(7):1139-41. PubMed ID: 19571374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the probability of target attainment between ceftriaxone and cefepime in the cerebrospinal fluid and serum against Streptococcus pneumoniae.
    Lodise TP; Nau R; Kinzig M; Jones RN; Drusano GL; Sörgel F
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):445-52. PubMed ID: 17512154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
    Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
    Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ceftriaxone in liver-transplant recipients.
    Toth A; Abdallah HY; Venkataramanan R; Teperman L; Halsf G; Rabinovitch M; Burckart GJ; Starzl TE
    J Clin Pharmacol; 1991 Aug; 31(8):722-8. PubMed ID: 1880231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic parameters of ceftriaxone after single intravenous and intramuscular administration in camels (Camelus Dromedarius).
    Goudah A
    Res Vet Sci; 2008 Jun; 84(3):483-9. PubMed ID: 17765938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery.
    Gergs U; Clauss T; Ihlefeld D; Weiss M; Pönicke K; Hofmann GO; Neumann J
    J Pharm Pharmacol; 2014 Nov; 66(11):1552-8. PubMed ID: 24941934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of ceftriaxone in Green sea turtles (Chelonia mydas) following intravenous and intramuscular administration at two dosages.
    Mapongpeng R; Laovechprasit W; Poapolathep A; Giorgi M; Junchompoo C; Sakulthaew C; Jermnak U; Passadurak W; Poapolathep S
    J Vet Pharmacol Ther; 2019 Jan; 42(1):104-110. PubMed ID: 30307622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
    Salamone P; Fuda G; Casale F; Marrali G; Lunetta C; Caponnetto C; Mazzini L; La Bella V; Mandrioli J; Simone IL; Moglia C; Calvo A; Tarella C; Chio A;
    BMJ Open; 2020 Mar; 10(3):e034049. PubMed ID: 32209625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone pharmacokinetic properties during continuous veno-veno haemofiltration using an in vitro adult, paediatric and neonatal model.
    Harvey B; Johnson TN; Yeomanson D; Mulla H; Mayer AP
    Perfusion; 2014 Jan; 29(1):32-8. PubMed ID: 23863489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ceftriaxone in freshwater crocodiles (Crocodylus siamensis) after intramuscular administration at two dosages.
    Poapolathep S; Giorgi M; Chaiyabutr N; Klangkaew N; Phaochoosak N; Wongwaipairote T; Poapolathep A
    J Vet Pharmacol Ther; 2020 Mar; 43(2):141-146. PubMed ID: 31353505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
    Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population Pharmacokinetics of Fixed Dose Combination of Ceftriaxone and Sulbactam in Healthy and Infected Subjects.
    Sharma VD; Singla A; Chaudhary M; Taneja M
    AAPS PharmSciTech; 2016 Oct; 17(5):1192-203. PubMed ID: 26644225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics, urinary and mammary excretion of ceftriaxone in lactating goats.
    Ismail MM
    J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):354-8. PubMed ID: 16109103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.